| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |